Prohance and cardiac arrest Patient Reports February 13, 2012

Prohance Side Effects Report #4559729-7
Prohance side effect was reported by a Health Professional from on Feb 19, 2004. Female patient, 32 years of age, was diagnosed with nuclear magnetic resonance imaging brain and was treated with Prohance. After drug was administered, patient experienced the following side effects: burning sensation, cardiac arrest , feeling hot, loss of consciousness. Prohance dosage: 20 ML ONCE IV. Patient was hospitalized. Patient recovered.

Prohance Side Effects Report #5627064-1
Prohance side effect was reported by a Health Professional from UNITED STATES on Jan 11, 2007. Male patient, 82 years of age, weighting 220.5 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Prohance. After drug was administered, patient experienced the following side effects: cardiac arrest , chest pain , pulse absent. Prohance dosage: 20 ML ONCE IV. During the same period patient was treated with LASIX SPECIAL, EASPRIN. Patient died on 01/08/2007.

Prohance Side Effects Report #6033033-2
Prohance side effect was reported by a Health Professional from UNITED STATES on July 03, 2008. Male patient, 74 years of age, weighting 220.5 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Prohance. After drug was administered, patient experienced the following side effects: anaphylactoid reaction, cardiac arrest . Prohance dosage: 3ML QD INTRAVENOUS (NOT OTHERWISE SPECIFIED. Patient was hospitalized. Patient recovered.

Prohance Side Effects Report #6032939-8
Prohance side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2008. Male patient, child 11 years of age, weighting 77.16 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Prohance. After drug was administered, patient experienced the following side effects: cardiac arrest , discomfort, endocardial fibrosis, joint contracture, metaplasia, mobility decreased, muscle contracture, myocardial fibrosis. Prohance dosage: unknown. During the same period patient was treated with MAGNEVIST, OMNISCAN. Patient was hospitalized and became disabled. Patient died on 01/17/2005.